Switzerland-based biopharma start-up Enzyvant has gained a double fast track status from the FDA for its new rare disease candidate RVT-802. The investigational tissue-based therapy is for the ...
Düsseldorf District Court issues preliminary injunction against Beijing Hanbaihan Medical Devices Co., Ltd. regarding ...
In its second pipeline-boosting deal in two days, Sanofi has pledged €469 million (around $490 million) upfront for rights to an anti-TL1A therapy being developed by Teva for inflammatory bowel ...
Christopher Pachel, DVM, DACVB, CABC, explains how veterinarians can tailor medication plans for dogs with separation anxiety by matching maintenance or situational drugs to each patient’s schedule ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback